4G4G genotype of the plasminogen activator inhibitor-1 promoter polymorphism associates with disseminated intravascular coagulation in children with systemic meningococcemia

被引:30
|
作者
Binder, A.
Endler, G.
Mueller, M.
Mannhalter, C.
Zenz, W.
机构
[1] Med univ Graz, Dept Gen Paediat, A-8036 Graz, Austria
[2] Med Univ Vienna, Inst Clin Med, Vienna, Austria
[3] Med Univ Vienna, Chem Lab Diagnost, Vienna, Austria
关键词
disseminated intravascular coagulation; fibrinogen; meningococcal disease; PAI-1; platelet count; polymorphism;
D O I
10.1111/j.1538-7836.2007.02724.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Meningococcal disease may present as sepsis, meningitis or a combination of both. Impaired fibrinolysis and massive elevation of the plasminogen activator inhibitor-1 (PAI-1) is a characteristic feature of meningococcal sepsis. We and others have reported an association between mortality and the functional 4G/5G promoter polymorphism of the PAI-1 gene in children with meningococcal sepsis. Objective: Multicenter study to investigate the association of the 4G/5G PAI-1 polymorphism and disseminated intravascular coagulation (DIC) in children with meningococcal disease in a Central European population. Patients/Methods: Blood samples and clinical information of 326 previously healthy children with meningococcal infection were collected from 95 pediatric hospitals in Germany, Switzerland, Italy, and Austria from 2000 to 2002. Results: DIC, defined as platelet counts below 100 G L-1, increased D-dimer levels and prolonged prothrombin time, was significantly associated with the 4G4G genotype [31 of 63 (49%) vs. 55 of 175 (31%), P = 0.014], resulting in a hazard ratio (HR) of 1.5 (95% confidence interval 1.1-2.1) to develop DIC. Carriers of the 4G4G genotype showed significantly lower platelet counts (183 G L-1 vs. 227 G L-1, P = 0.009) on admission. Fibrinogen and C-reactive protein levels were not associated with the PAI-1 4G/5G polymorphism, nor were white blood cell counts. Conclusions: Our data show a correlation between the 4G4G genotype of the PAI-1 gene and development of DIC in meningococcal infection.
引用
收藏
页码:2049 / 2054
页数:6
相关论文
共 50 条
  • [31] Plasminogen activator inhibitor-1 4G/5G polymorphism and retinopathy risk in type 2 diabetes: a meta-analysis
    Zhang, Tengyue
    Pang, Chong
    Li, Ningdong
    Zhou, Elaine
    Zhao, Kanxing
    BMC MEDICINE, 2013, 11
  • [32] Plasminogen activator inhibitor-1 4G/5G polymorphism and retinopathy risk in type 2 diabetes: a meta-analysis
    Tengyue Zhang
    Chong Pang
    Ningdong Li
    Elaine Zhou
    Kanxing Zhao
    BMC Medicine, 11
  • [33] Genotype frequency of plasminogen activator inhibitor-1 (PAI-1) 4G/5G polymorphism in healthy Japanese males and its relation to PAI-1 levels
    Matsubara, Y
    Murata, M
    Isshiki, I
    Watanabe, R
    Zama, T
    Watanabe, G
    Watanabe, K
    Ikeda, Y
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 1999, 69 (01) : 43 - 47
  • [34] Plasminogen activator inhibitor-1 C/G polymorphism in relation to plasma levels in rheumatoid arthritis
    Torres-Carrillo, Norma
    Torres-Carrillo, Nora Magdalena
    Martinez-Bonilla, Gloria Esther
    Vazquez-Del Mercado, Monica
    Palafox-Sanchez, Claudia Azucena
    Oregon-Romero, Edith
    Bernard-Medina, Ana Guilaisne
    Rangel-Villalobos, Hector
    Munoz-Valle, Jose Francisco
    CLINICAL AND EXPERIMENTAL MEDICINE, 2009, 9 (03) : 223 - 228
  • [35] Plasminogen activator inhibitor-1 C/G polymorphism in relation to plasma levels in rheumatoid arthritis
    Norma Torres-Carrillo
    Nora Magdalena Torres-Carrillo
    Gloria Esther Martínez-Bonilla
    Mónica Vázquez-Del Mercado
    Claudia Azucena Palafox-Sánchez
    Edith Oregón-Romero
    Ana Guilaisne Bernard-Medina
    Héctor Rangel-Villalobos
    José Francisco Muñoz-Valle
    Clinical and Experimental Medicine, 2009, 9 : 223 - 228
  • [36] Association of the Plasminogen Activator Inhibitor-1 (PAI-1) Gene-675 4G/5G and-844 A/G Promoter Polymorphism with Risk of Keloid in a Chinese Han Population
    Wang, Yongjie
    Long, Jianhong
    Wang, Xiaoyan
    Sun, Yang
    MEDICAL SCIENCE MONITOR, 2014, 20 : 2069 - 2073
  • [37] Association between plasminogen activator inhibitor-1 (PAI-1) 4G/5G polymorphism and circulating PAI-1 level in systemic lupus erythematosus and rheumatoid arthritis A meta-analysis
    Bae, S-C
    Lee, Y. H.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2020, 79 (03): : 312 - 318
  • [38] Plasminogen activator inhibitor-1 4G/5G polymorphism in breast cancer patients and its association with tissue PAI-1 levels and tumor severity
    Castelló, R
    España, F
    Vázquez, C
    Fuster, C
    Almenar, SM
    Aznar, J
    Estellés, A
    THROMBOSIS RESEARCH, 2006, 117 (05) : 487 - 492
  • [39] Plasminogen activator inhibitor-1 (PAI-1) content in platelets from healthy individuals genotyped for the 4G/5G polymorphism in the PAI-1 gene
    Nordenhem, A
    Wiman, B
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1997, 57 (05) : 453 - 461
  • [40] The common -675 4G/5G polymorphism in the plasminogen activator inhibitor –1 gene is strongly associated with obesity
    J. Hoffstedt
    I.-L. Andersson
    L. Persson
    B. Isaksson
    P. Arner
    Diabetologia, 2002, 45 : 584 - 587